173 related articles for article (PubMed ID: 34516342)
1. TTK (threonine tyrosine kinase) regulates the malignant behaviors of cancer cells and is regulated by microRNA-582-5p in ovarian cancer.
Lu N; Ren L
Bioengineered; 2021 Dec; 12(1):5759-5768. PubMed ID: 34516342
[TBL] [Abstract][Full Text] [Related]
2. F-Box and Leucine-Rich Repeat Protein 20 (FBXL20), Negatively Regulated by microRNA (miR)-195-5p, Accelerates the Malignant Progression of Ovarian Cancer.
Wu D; Liu C; Hong L
Mol Biotechnol; 2021 Dec; 63(12):1235-1243. PubMed ID: 34338995
[TBL] [Abstract][Full Text] [Related]
3. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
Yang X; Zhou S; Yang C; Cao C; He M; Zi S
Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
[TBL] [Abstract][Full Text] [Related]
4. Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network.
Jin Y; Wang H
J Ovarian Res; 2022 Jan; 15(1):3. PubMed ID: 34983607
[TBL] [Abstract][Full Text] [Related]
5. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
6. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
Zhang C; Li Y; Zhao W; Liu G; Yang Q
Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
[TBL] [Abstract][Full Text] [Related]
7. microRNA-1271-5p/TIAM1 suppresses the progression of ovarian cancer through inactivating Notch signaling pathway.
Han FJ; Li J; Shen Y; Guo Y; Liu YC; Yu Y; Xu JY; Liu SX; Wang YH
J Ovarian Res; 2020 Sep; 13(1):110. PubMed ID: 32948241
[TBL] [Abstract][Full Text] [Related]
8. Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p.
Jiang JN; Hong QY; Gao HJ; Lai BL; Lan JF; Yang Q
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1388-1396. PubMed ID: 30840259
[TBL] [Abstract][Full Text] [Related]
9. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-139-5p Inhibits Cell Proliferation and Invasion by Targeting RHO-Associated Coiled-Coil-Containing Protein Kinase 2 in Ovarian Cancer.
Wang Y; Li J; Xu C; Zhang X
Oncol Res; 2018 Apr; 26(3):411-420. PubMed ID: 28653604
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
Zhang H; Zhang K; Xu Z; Chen Z; Wang Q; Wang C; Cui J
BMC Cancer; 2021 Feb; 21(1):163. PubMed ID: 33588776
[TBL] [Abstract][Full Text] [Related]
13. CDCA5 is negatively regulated by miR-326 and boosts ovarian cancer progression.
Gao A; Hu Y; Zhu W
J BUON; 2021; 26(2):544-552. PubMed ID: 34077004
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA miR-502-5p inhibits ovarian cancer genesis by downregulation of GINS complex subunit 2.
Zhan L; Yang J; Liu Y; Cheng Y; Liu H
Bioengineered; 2021 Dec; 12(1):3336-3347. PubMed ID: 34288816
[TBL] [Abstract][Full Text] [Related]
15. HLF/miR-132/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells.
Chen S; Wang Y; Ni C; Meng G; Sheng X
Biomed Pharmacother; 2016 Oct; 83():898-904. PubMed ID: 27522003
[TBL] [Abstract][Full Text] [Related]
16. HOTAIRM1 suppresses cell proliferation and invasion in ovarian cancer through facilitating ARHGAP24 expression by sponging miR-106a-5p.
Chao H; Zhang M; Hou H; Zhang Z; Li N
Life Sci; 2020 Feb; 243():117296. PubMed ID: 31935390
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-1271-5p inhibits the tumorigenesis of ovarian cancer through targeting E2F5 and negatively regulates the mTOR signaling pathway.
Li Q; Shi J; Xu X
Panminerva Med; 2021 Sep; 63(3):336-342. PubMed ID: 32414231
[TBL] [Abstract][Full Text] [Related]
18. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
Wang L; Yu M; Zhao S
J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
[TBL] [Abstract][Full Text] [Related]
19. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.
Miao Y; Konno Y; Wang B; Zhu L; Zhai T; Ihira K; Kobayashi N; Watari H; Jin X; Yue J; Dong P; Fang M
J Transl Med; 2023 Feb; 21(1):151. PubMed ID: 36829176
[TBL] [Abstract][Full Text] [Related]
20. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.
Zuo L; Li X; Tan Y; Zhu H; Xiao M
J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
